<?xml version="1.0" encoding="UTF-8"?>
<p>The use of hematopoietic colony‐stimulating factors to prevent chemotherapy‐induced neutropenia is not routine with most chemotherapy protocols. There is no evidence to support a greater use of such factors to prevent neutropenia during a pandemic, especially considering that it also would increase the cost of treatment at a time when health care budgets will be severely strained 
 <xref rid="onco13306-bib-0009" ref-type="ref">9</xref>.
</p>
